riluzole has been researched along with Ventricular Dysfunction, Left in 1 studies
Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.
Ventricular Dysfunction, Left: A condition in which the LEFT VENTRICLE of the heart was functionally impaired. This condition usually leads to HEART FAILURE; MYOCARDIAL INFARCTION; and other cardiovascular complications. Diagnosis is made by measuring the diminished ejection fraction and a depressed level of motility of the left ventricular wall.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Weiss, S | 1 |
| Benoist, D | 1 |
| White, E | 1 |
| Teng, W | 1 |
| Saint, DA | 1 |
1 other study available for riluzole and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Riluzole protects against cardiac ischaemia and reperfusion damage via block of the persistent sodium current.
Topics: Action Potentials; Animals; Calcium; Dose-Response Relationship, Drug; Electrocardiography; Heart; M | 2010 |